Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 60

Results For "marketing"

818 News Found

Malaysia awards three-year contract for Biocon Biologics’ Insugen
Biotech | April 26, 2022

Malaysia awards three-year contract for Biocon Biologics’ Insugen

Biocon Biologics’ Insugen formulations will be available to patients at all Ministry of Health hospitals, district health offices and health clinics


Pharming gets positive review from UK MHRA for leniolisib
Biotech | April 26, 2022

Pharming gets positive review from UK MHRA for leniolisib

A Promising Innovative Medicine (PIM) designation is an early indication that leniolisib is a candidate for the MHRA's Early Access to Medicines Scheme


Marskans Pharma acquires Dubai based Access Healthcare
News | April 25, 2022

Marskans Pharma acquires Dubai based Access Healthcare

Access Healthcare for Medical Products (Access Healthcare) provides pharmaceutical companies with innovative marketing and sales solutions in the MENA (Middle East & North Africa) region


Global AYUSH meet ends with promise of Rs 9000 cr. in investment
News | April 25, 2022

Global AYUSH meet ends with promise of Rs 9000 cr. in investment

Investment and innovation opportunities in the field of AYUSH are limitless : Sarbananda Sonowal


CHMP adopts positive opinion on Tabrecta for advanced non-small cell lung cancer
Biotech | April 23, 2022

CHMP adopts positive opinion on Tabrecta for advanced non-small cell lung cancer

With one of the most diverse lung cancer development programs, Novartis is focused on investments to advance the science, drive treatment and make an impact on patients


Qvella FAST System and FAST-PBC get CE marked and USFDA listed
Biotech | April 22, 2022

Qvella FAST System and FAST-PBC get CE marked and USFDA listed

With the commercialization of Qvella technology for Positive Blood Culture (PBC) processing, healthcare facilities can now get results up to 24 hours faster than current methods


Merck announces Joseph Romanelli will lead Merck Human Health International
News | April 21, 2022

Merck announces Joseph Romanelli will lead Merck Human Health International

In this role, Romanelli will have P&L responsibility for Merck’s US $22 billion international human health business and lead a team of 14,000 colleagues in more than 75 markets outside of the U.S


Lupin engages Flutura to accelerate digitial drive using AI
News | April 21, 2022

Lupin engages Flutura to accelerate digitial drive using AI

Flutura to deploy Cerebra Digital Twin & Pharmacologist Workbench, a self-service AI platform to accelerate impact on Pharmaceutical outcomes


Boehringer Ingelheim launches RenuTend to heal ligament injuries in horses
Drug Approval | April 21, 2022

Boehringer Ingelheim launches RenuTend to heal ligament injuries in horses

Targeted action improves quality of healing of tendon and suspensory ligament injuries in horses


Purigen launches ionic cells to pure DNA kit
Biotech | April 21, 2022

Purigen launches ionic cells to pure DNA kit

New kit enhances menu of FFPE solutions and allows oncology researchers to extract higher yields of concentrated DNA compared to traditional techniques